WOOM has raised $510K in total across 1 funding round.
WOOM's investors include TheVentureCity.
WOOM is a women's health technology company, specifically a FemTech startup, that develops a mobile app to support women across their reproductive lifecycle—from contraception and fertility tracking to pregnancy and menopause. The app analyzes over 100 biometric, cycle, and lifestyle parameters (including menstrual data, age, and habits) to predict fertility windows, pregnancy chances, and provide personalized health insights, helping users conceive naturally or seek timely medical advice.[1][2] It serves women primarily in Spanish-speaking countries like Spain, Mexico, Colombia, Chile, Argentina, and Peru, with expansion to the USA, UK, and Singapore, boasting 1.3 million registered users, 900,000 downloads, and over 128,000 women helped to conceive within three years.[1][2] Partnerships with firms like Ferring Pharmaceuticals and MAPFRE have accelerated growth by integrating trusted medical expertise and enhancing user reach in women's health.[1][2]
WOOM was co-founded by Laurence Fontinoy (CEO) and Clelia Morales (co-CEO), driven by their personal experiences with pregnancy and the need for reliable, personalized fertility information.[1][2] Emerging around 2019, the app launched initially in Spanish for Latin American and Spanish markets, quickly gaining traction with medical professional partnerships to ensure accuracy.[1] Early milestones include surpassing 600,000 users by mid-2019 and collaborations like the one with Ferring Pharmaceuticals, which aimed to shorten fertility journeys for one in six couples facing conception challenges.[1] This personal-to-global evolution humanizes WOOM as a response to unmet needs in women's health data trust and accessibility.[2]
WOOM stands out in the FemTech space through these key strengths:
WOOM rides the FemTech wave, a booming sector addressing $50B+ women's health gaps through data-driven apps amid rising demand for personalized reproductive care post-pandemic.[1][2] Timing aligns with global fertility declines (e.g., one in six couples struggling) and digital health adoption, amplified by Spanish-language focus in underserved Latin markets.[1] Favorable forces include insurer integrations (e.g., MAPFRE) and pharma alliances (e.g., Ferring), positioning WOOM to influence ecosystem standards for precise, inclusive fertility tech while expanding to English markets like the US and UK.[2]
WOOM's trajectory points to multinational scaling, leveraging its data moat and partnerships to hit 5M+ users, potentially via AI-enhanced predictions and global localization. Trends like menopause tech and male fertility inclusion will shape growth, evolving WOOM from niche fertility app to comprehensive women's health platform—influencing FemTech by proving community-data hybrids drive real outcomes. This builds on its mission to empower women with trusted insights, accelerating family-building in a data-scarce world.[1][2]
WOOM has raised $510K across 1 funding round. Most recently, it raised $510K Seed in March 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2017 | $510K Seed | TheVentureCity |
